DSM-Firmenich AG (AMS:DSFIR)

Netherlands flag Netherlands · Delayed Price · Currency is EUR
74.32
0.00 (0.00%)
Oct 8, 2025, 5:35 PM CET
Market Cap18.97B
Revenue (ttm)13.01B
Net Income (ttm)718.00M
Shares Out255.18M
EPS (ttm)2.72
PE Ratio27.36
Forward PE18.36
Dividend2.50 (3.36%)
Ex-Dividend DateMay 8, 2025
Volume632,491
Average Volume807,279
Open73.86
Previous Close74.32
Day's Range73.10 - 74.34
52-Week Range70.94 - 119.35
Beta0.98
RSI39.77
Earnings DateFeb 12, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Sector Materials
Founded 1902
Employees 26,301
Stock Exchange Euronext Amsterdam
Ticker Symbol DSFIR
Full Company Profile

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial Statements

News

How high-cost Switzerland stayed a manufacturing powerhouse in the offshore era

What is the lesson of Swiss Fortune 500 companies—such as DSM-Firmenich—for the rest of Europe, and the world?

6 days ago - Fortune

DSM-Firmenich (DSFIY) Reopens Auction for Animal Nutrition Unit

DSM-Firmenich (DSFIY) Reopens Auction for Animal Nutrition Unit

11 days ago - GuruFocus

Apollo asked to rejoin DSM-Firmenich’s auction as CVC bid stalls: report

Apollo Global Management (NYSE:APO) has been asked to rejoin in the auction of DSM-Firmenich's (KDSKF) animal nutrition and health unit. Read more here.

11 days ago - Seeking Alpha

DSM-Firmenich is a smarter, faster working engine post merger, says CEO

Dimitri De Vreeze, CEO of Dsm-Firmenich, talks about the company's merger and share buyback program off the back of its full-year earning results.

8 months ago - CNBC

Reducing Cattle’s Footprint

Cow flatulence is a significant contributor to the greenhouse gas in our atmosphere. Dutch company DSM-Firmenich’s Bovaer addresses that issue at source: The feed additive slows down the last step of ...

1 year ago - TIME

Pavel Bittner birla por una llanta un sprint de foto-finish a Van Aert

El joven checo de 21 aos, del Team DSM-Firmenich, logr su tercera victoria de etapa como profesional

1 year ago - La Vanguardia

DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...

1 year ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...

1 year ago - Seeking Alpha

Royal DSM: Quality At A Price

Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.

3 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript

Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi...

3 years ago - Seeking Alpha

Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay

Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.

3 years ago - CNBC International TV

'A merger of equals': Firmenich CEO Ghostine on DSM deal

Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."

3 years ago - CNBC International TV

5 Great Green Stocks Making a Direct Impact

It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.

3 years ago - Kiplinger

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

DSM co-CEO: Inflationary pressures offset by 4% price increase in some business areas

Geraldine Matchett, co-CEO of DSM and member of CNBC's ESG Council, provides a deep dive into the company's fourth-quarter results and shares how DSM are tackling rising inflation.

3 years ago - CNBC International TV

Very Confident to Increase Our Outlook: DSM Co-CEO

Aug.04 -- DSM Co-CEO Dimitri de Vreeze discusses the company's earnings, emissions and sustainable foods. He speaks with Bloomberg's Anna Edwards and Mark Cudmore on "Bloomberg: European Market Open".

4 years ago - Bloomberg Markets and Finance

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

5 years ago - Seeking Alpha